First needle less COVID vaccines for children and adult above 12 years got approval for EUA


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Zydus Cadila’s ZyCov-D, Covid vaccine got Emergency Use Authorization for children and adults 12 years and above

The drug regulator of India approved Zydus Cadila’s three-dose COVID19 DNA vaccine for emergency use authorization for children 12 years and above. This is the second homegrown vaccine that has got approval against the deadly COVID19 infection. 

The company has applied for authorization of ZyCov-D on July 1st. It has an efficacy rate of 66.66 % in a late-stage trial of more than 28,000 volunteers nationwide. The company has developed vaccines in partnership with the Department of Biotechnology. ZyCoV-D is the world's first plasmid DNA vaccine against coronavirus. The company has planned to manufacture 100-120 million doses annually.

All about ZyCov-D

ZyCov-D is a three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus. ZyCov-D is effective against mutant strains of virus-like delta variants which are highly infectious. It will be administered on the 1st day – 28th day – 56th day. It elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance. It is an intradermal vaccine, applied using a ‘needle-free injector’. A needle-free system can lead to a significant reduction in side effects. The vaccine has been developed in partnership with the department under Mission COVID Suraksha.

It is the world's first and India's indigenously developed DNA-based vaccine for COVID-19 to be administered in humans including children and adults 12 years and above. Bharat Biotech’s Covaxin and ZydusCadila’s ZyCov-D are the only two vaccine candidates to have been tested among children in India and developed in India. 

Tags : #Spotlight #ZyCov-D #Covaxin #COVIDVaccine #Firstcovidvaccineforchildren12yearsandabove #NeedlelessCOVIDVaccine #ZydusCadila #Medicircle #SmitaKumar

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026